Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Downar

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) ReportKatharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND reportNikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Expansion of a frontostriatal salience network in individuals with depressionCharles J Lynch, Immanuel Elbau, Tommy Ng, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 19, 2020
Precision non-implantable neuromodulation therapies: a perspective for the depressed brainLucas Borrione, Helena Bellini, Lais Boralli Razza, et al.
Nature|September 4, 2024
Frontostriatal salience network expansion in individuals in depressionCharles J Lynch, Immanuel G Elbau, Tommy Ng, et al.
Journal of Psychiatry & Neuroscience : JPN|March 7, 2019
The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocolsGlenda M. MacQueen, Stefanie Hassel, Stephen R. Arnott, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Objective Quality Assessment for Precision Functional MRI DataCharles J Lynch, Megan Chang, Immanuel Elbau, et al.
Neuron|June 22, 2026
Objective quality assessment for precision functional MRI dataCharles J Lynch, Megan Chang, Immanuel Elbau, et al.
BMC Psychiatry|April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohortRaymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) ReportKatharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND reportNikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Expansion of a frontostriatal salience network in individuals with depressionCharles J Lynch, Immanuel Elbau, Tommy Ng, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 19, 2020
Precision non-implantable neuromodulation therapies: a perspective for the depressed brainLucas Borrione, Helena Bellini, Lais Boralli Razza, et al.
Nature|September 4, 2024
Frontostriatal salience network expansion in individuals in depressionCharles J Lynch, Immanuel G Elbau, Tommy Ng, et al.
Journal of Psychiatry & Neuroscience : JPN|March 7, 2019
The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocolsGlenda M. MacQueen, Stefanie Hassel, Stephen R. Arnott, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Objective Quality Assessment for Precision Functional MRI DataCharles J Lynch, Megan Chang, Immanuel Elbau, et al.
Neuron|June 22, 2026
Objective quality assessment for precision functional MRI dataCharles J Lynch, Megan Chang, Immanuel Elbau, et al.
BMC Psychiatry|April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohortRaymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Pageof 20